Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,400 | 74,400 | 91,800 | 102,400 | 99,900 |
| Receivables | 118,000 | 137,000 | 120,400 | 121,200 | 125,700 |
| Inventories | 31,600 | 28,700 | 28,300 | 27,500 | 26,200 |
| TOTAL | $344,800 | $284,300 | $287,200 | $298,000 | $293,200 |
| Non-Current Assets | |||||
| PPE Net | 111,400 | 113,000 | 114,000 | 117,400 | 115,400 |
| Intangibles | 214,700 | 221,700 | 543,800 | 548,700 | 598,800 |
| Other Non-Current Assets | 57,200 | 58,300 | 61,100 | 63,500 | 73,900 |
| TOTAL | $383,300 | $393,000 | $718,900 | $729,600 | $788,100 |
| Total Assets | $728,100 | $677,300 | $1,006,100 | $1,027,600 | $1,081,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 59,400 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 31,800 | 30,900 | 28,100 | 32,300 | 29,600 |
| Accrued Expenses | 108,300 | 100,600 | 112,100 | 119,000 | 111,200 |
| TOTAL | $148,000 | $199,900 | $151,100 | $164,100 | $154,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 119,500 | 0 | 59,300 | 39,600 | 39,000 |
| Other Non-Current Liabilities | 87,800 | 89,300 | 90,800 | 122,800 | 156,300 |
| TOTAL | $207,300 | $89,300 | $150,100 | $162,400 | $195,300 |
| Total Liabilities | $355,300 | $289,200 | $301,200 | $326,500 | $349,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,214 | 93,045 | 92,177 | 91,309 | 91,035 |
| Common Shares | 900 | 900 | 900 | 900 | 900 |
| Retained earnings | -1,114,800 | -1,087,400 | -756,900 | -756,800 | -714,300 |
| Other shareholders' equity | -100 | -100 | -600 | -800 | -100 |
| TOTAL | $372,800 | $388,100 | $704,900 | $701,100 | $731,700 |
| Total Liabilities And Equity | $728,100 | $677,300 | $1,006,100 | $1,027,600 | $1,081,300 |